FANELLI, TIZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.953
EU - Europa 1.361
AS - Asia 266
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.585
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.950
PL - Polonia 496
RU - Federazione Russa 415
IE - Irlanda 108
IT - Italia 103
CN - Cina 83
SE - Svezia 81
SG - Singapore 67
HK - Hong Kong 49
DE - Germania 40
CH - Svizzera 33
JO - Giordania 30
FR - Francia 24
FI - Finlandia 22
IN - India 21
ES - Italia 16
GB - Regno Unito 12
VN - Vietnam 10
BE - Belgio 4
UA - Ucraina 4
CA - Canada 3
NL - Olanda 3
CI - Costa d'Avorio 2
KR - Corea 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
EU - Europa 1
MU - Mauritius 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.585
Salva come PNG Salva come JPEG
Città #
Warsaw 496
Fairfield 297
Santa Clara 280
Ashburn 173
Chandler 158
Woodbridge 137
Seattle 127
Cambridge 111
Dublin 108
Houston 98
Wilmington 89
Ann Arbor 53
Altamura 48
Lawrence 42
Beijing 40
Singapore 40
Princeton 39
Bern 33
Hong Kong 30
Buffalo 25
Bremen 24
Florence 23
Boston 20
Shanghai 19
Mumbai 18
Barcelona 16
Los Angeles 11
Boardman 10
Dong Ket 10
Kent 10
San Diego 10
Medford 9
Norwalk 7
Dearborn 6
New York 6
Falls Church 5
Jacksonville 5
Phoenix 5
Brussels 4
Hillsboro 4
Redwood City 4
Romainville 4
Fuzhou 3
London 3
Montevarchi 3
Pune 3
Toronto 3
Yubileyny 3
Abidjan 2
Burghausen 2
Cantagallo 2
Costa Mesa 2
Helsinki 2
Jinan 2
Nürnberg 2
Paris 2
Seoul 2
Tappahannock 2
Abu Dhabi 1
Andover 1
Augusta 1
Azzano San Paolo 1
Carate Brianza 1
Caronno Pertusella 1
Chicago 1
Chiswick 1
Fremont 1
Harbin 1
Heze 1
Islington 1
Izmir 1
Kaohsiung 1
Monteroni D'arbia 1
Moscow 1
Munich 1
Naaldwijk 1
Nanchang 1
Nanjing 1
Prato 1
Quito 1
Riyadh 1
Shenyang 1
Shenzhen 1
Southwark 1
Sovicille 1
Villa Minozzo 1
Wuhan 1
Wuhu 1
Xian 1
Totale 2.723
Salva come PNG Salva come JPEG
Nome #
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 268
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 263
EZH2 mutational status predicts poor survival in myelofibrosis. 252
Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group 172
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 163
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 161
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients 154
Targeted deep sequencing in polycythemia vera and essential thrombocythemia 149
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms 144
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis 142
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib 138
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib 135
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 129
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 125
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 124
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients 120
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 120
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 118
Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis. 112
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 112
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. 108
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. 101
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 89
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells unveils the role of miR-155/JARID2 axis in abnormal megakaryopoiesis. 88
Prognotic Impact of Mutations in Systemic Mastocytosis 85
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 83
Totale 3.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020580 0 0 0 0 94 90 90 95 81 57 55 18
2020/2021408 32 44 7 73 20 20 22 34 39 64 39 14
2021/2022195 3 18 20 8 3 6 5 21 8 9 39 55
2022/2023671 52 144 41 52 45 94 72 44 70 1 19 37
2023/2024204 2 21 24 8 21 22 3 74 2 4 13 10
2024/2025858 40 146 86 240 346 0 0 0 0 0 0 0
Totale 3.655